These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12825028)

  • 21. [Local application of cidofovir as adjuvant therapy in recurrent laryngeal papillomatosis in children].
    Pontes P; Weckx LL; Pignatari SS; Fujita RR; Avelino MA; Sato J
    Rev Assoc Med Bras (1992); 2009; 55(5):581-6. PubMed ID: 19918660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Observations on the early results of treatment of recurrent respiratory papillomatosis using cidofovir.
    El Hakim H; Waddell AN; Crysdale WS
    J Otolaryngol; 2002 Dec; 31(6):333-5. PubMed ID: 12593542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stepped-dose protocol of cidofovir therapy in recurrent respiratory papillomatosis in children.
    Akst LM; Lee W; Discolo C; Knott D; Younes A; Koltai PJ
    Arch Otolaryngol Head Neck Surg; 2003 Aug; 129(8):841-6. PubMed ID: 12925342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intralesional Cidofovir application in recurrent laryngeal papillomatosis.
    Pudszuhn A; Welzel C; Bloching M; Neumann K
    Eur Arch Otorhinolaryngol; 2007 Jan; 264(1):63-70. PubMed ID: 17058091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The schedule of intralesional papillomatosis treatment with cidofovir].
    Szyfter W; Wierzbicka M; Jackowska J; Bartochowska A; Banaszewski J
    Otolaryngol Pol; 2010; 64(2):98-102. PubMed ID: 20568538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intralesional cidofovir as adjuvant for the successful management of aggressive respiratory papillomatosis in an infant.
    Durvasula VS; Richter GT
    Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1912-5. PubMed ID: 24063771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3.5-Year follow-up of intralesional cidofovir protocol for pediatric recurrent respiratory papillomatosis.
    Chung BJ; Akst LM; Koltai PJ
    Int J Pediatr Otorhinolaryngol; 2006 Nov; 70(11):1911-7. PubMed ID: 16919339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intralesional or topical cidofovir (HPMPC, VISTIDE) for the treatment of recurrent genital warts in HIV-1-infected patients.
    Orlando G; Fasolo MM; Beretta R; Signori R; Adriani B; Zanchetta N; Cargnel A
    AIDS; 1999 Oct; 13(14):1978-80. PubMed ID: 10513659
    [No Abstract]   [Full Text] [Related]  

  • 29. Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis.
    Broekema FI; Dikkers FG
    Eur Arch Otorhinolaryngol; 2008 Aug; 265(8):871-9. PubMed ID: 18458927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serial office-based intralesional injection of cidofovir in adult-onset recurrent respiratory papillomatosis.
    Co J; Woo P
    Ann Otol Rhinol Laryngol; 2004 Nov; 113(11):859-62. PubMed ID: 15562893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is cidofovir a useful adjunctive therapy for recurrent respiratory papillomatosis in children?
    Peyton Shirley W; Wiatrak B
    Int J Pediatr Otorhinolaryngol; 2004 Apr; 68(4):413-8. PubMed ID: 15013606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Office-based treatment of laryngeal papillomatosis with percutaneous injection of cidofovir.
    Chhetri DK; Blumin JH; Shapiro NL; Berke GS
    Otolaryngol Head Neck Surg; 2002 Jun; 126(6):642-8. PubMed ID: 12087331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Respiratory papillomatosis--new methods of treatment].
    Nowaczewska K; Wójtowicz P; Kukwa A; Ratajczak J; Tulibacki M
    Otolaryngol Pol; 2010; 64(1):31-6. PubMed ID: 20476590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intralesional cidofovir in severe juvenile respiratory papillomatosis.
    Ablanedo-Terrazas Y; Soda-Merhy A; Hernández-Palestina M; Ormsby CE; Reyes-Terán G
    B-ENT; 2012; 8(3):197-202. PubMed ID: 23113383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide®).
    Tjon Pian Gi RE; Dietz A; Djukic V; Eckel HE; Friedrich G; Golusinski W; Hantzakos A; Lawson G; Remacle M; Rihkanen H; Dikkers FG
    Eur Arch Otorhinolaryngol; 2012 Feb; 269(2):361-2. PubMed ID: 22020697
    [No Abstract]   [Full Text] [Related]  

  • 36. Intralesional cidofovir injection for recurrent respiratory papillomatosis in Japan.
    Murono S; Nakanishi Y; Tsuji A; Endo K; Kondo S; Wakisaka N; Yoshizaki T
    Auris Nasus Larynx; 2016 Oct; 43(5):541-5. PubMed ID: 26860235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel method of intralesional cidofovir injection into laryngotracheal papillomata.
    Sahota RS; Uddin FJ; Al-Shukri J; Moir AA
    J Laryngol Otol; 2011 Apr; 125(4):402-4. PubMed ID: 21281536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects.
    Zabawski EJ; Cockerell CJ
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):741-5. PubMed ID: 9810890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis.
    Clamp PJ; Saunders MW
    Int J Pediatr Otorhinolaryngol; 2013 Mar; 77(3):323-8. PubMed ID: 23369614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current use of intralesional cidofovir for recurrent respiratory papillomatosis.
    Derkay CS; Volsky PG; Rosen CA; Pransky SM; McMurray JS; Chadha NK; Froehlich P
    Laryngoscope; 2013 Mar; 123(3):705-12. PubMed ID: 23070868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.